Welcome to our dedicated page for Nano-X Imaging news (Ticker: NNOX), a resource for investors and traders seeking the latest updates and insights on Nano-X Imaging stock.
NANO-X IMAGING LTD reports news on an integrated medical imaging and healthcare services platform built around Nanox.ARC multisource digital tomosynthesis systems, AI and software solutions, cloud-based workflow tools, remote radiology access, health information technology and a marketplace model. Company updates commonly cover U.S. commercialization, distribution agreements, clinical collaborations and regulatory clearances tied to Nanox.ARC and related imaging capabilities.
Recurring financial and operating news also includes results from teleradiology services, imaging products and services, AI and software activity, and the completed addition of Nanox Health IT. The company frames its commercial activity around broader access to 3D imaging and preventive-care workflows across clinical settings.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Nano-X Imaging Ltd (Nasdaq: NNOX) has announced a strategic partnership with Ferrum Health to enhance its AI technologies for medical imaging. This collaboration aims to integrate Nanox.AI’s solutions, including the HealthOST and HealthCCSng applications, into Ferrum Health's platform. The partnership focuses on improving the adoption of AI in healthcare, providing advanced analytics for chronic disease detection, and enhancing patient outcomes. Ferrum's platform has already analyzed over 750,000 patient records, further solidifying their position in the AI healthcare space. Both companies aim to democratize access to innovative clinical AI technologies globally.
NANO-X IMAGING LTD (NASDAQ: NNOX) reported its fourth quarter 2022 results, concluding the year with $8.6 million in total revenue. The company generated $2.1 million in Q4, a slight decrease from $2.4 million in Q3. A significant net loss of $44.8 million was noted, largely due to a $36.5 million goodwill impairment. Cash and marketable securities stood at $102.9 million as of December 31, 2022. Key developments included the deployment of a Nanox.ARC system in Ghana and plans for a system in Nigeria, alongside a partnership with Nuance Precision Imaging Network to expand AI solutions. The conference call is scheduled for March 9, 2023.